Source MDx to Participate in Breakout Session Focused on Companion Diagnostics at the 2007 Biotechnology Industry Organization (BIO) International Convention

BOULDER, CO -- (MARKET WIRE) -- May 03, 2007 -- Source MDx, a molecular diagnostics company, announced today that it will be participating in a session entitled "Twinning" Strategies: The Business of Companion Diagnostics and Targeted Therapies at the 2007 BIO International Convention. Karl Wassmann, CEO and President, will provide an overview of the benefits of biomarkers and companion diagnostics, and discuss how these tools can enable pharmaceutical and biotech companies to economically develop targeted therapies.